ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,740Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 194

$749K Total Retail Price of All Prescriptions

Rank: 16 out of 194

686 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
0% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 16,611 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $36 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
METOPROLOL SUCCINATE 1,049 994 1 4
SIMVASTATIN 948 889 2 1
AMLODIPINE BESYLATE 948 893 2 2
LOSARTAN-HYDROCHLOROTHIAZIDE 748 688 4 5
GLIMEPIRIDE 581 535 5 29
LOSARTAN POTASSIUM 573 540 6 3
LEVOTHYROXINE SODIUM 483 447 7 20
SYNTHROID 379 340 8 17
DIGOXIN 365 351 9 26
ATENOLOL 362 344 10 7
CLOPIDOGREL 344 340 11 16
GABAPENTIN 343 326 12 21
FUROSEMIDE 307 294 13 14
ATORVASTATIN CALCIUM 295 284 14 10
PLAVIX 281 280 15 18
ISOSORBIDE MONONITRATE ER 262 262 16 12
LISINOPRIL 262 227 16 11
METFORMIN HCL 253 203 18 9
OMEPRAZOLE 230 217 19 23
ZOLPIDEM TARTRATE 207 185 20 42
DIOVAN 205 202 21 32
TRIAMTERENE-HCTZ 192 178 22 67
AMLODIPINE BESYLATE-BENAZEPRIL 188 185 23 30
LANSOPRAZOLE 187 176 24 79
METFORMIN HCL ER 187 171 24 61
TRAMADOL HCL-ACETAMINOPHEN 182 168 26 54
HYDROCHLOROTHIAZIDE 176 160 27 13
CARVEDILOL 172 160 28 8
RANITIDINE HCL 160 139 29 22
CRESTOR 160 148 29 27
ENALAPRIL MALEATE 157 149 31 6
DOXAZOSIN MESYLATE 146 133 32 19
ALENDRONATE SODIUM 133 131 33 52
VERAPAMIL ER 121 121 34 34
CLONIDINE HCL 121 80 34 45
WARFARIN SODIUM 117 117 36 28
ATACAND 114 111 37 68
METOPROLOL TARTRATE 111 110 38 15
PAROXETINE HCL 111 109 38 116
NAMENDA 110 110 40 109
IRBESARTAN 105 83 41 31
PROPRANOLOL HCL 103 98 42 92
DONEPEZIL HCL 97 87 43 76
VYTORIN 96 89 44 53
DIOVAN HCT 96 80 44 35
TRICOR 92 87 46 66
JANUVIA 91 72 47 82
ALLOPURINOL 88 82 48 69
NABUMETONE 85 80 49 96
JANUMET 85 79 49 102
MECLIZINE HCL 82 78 51 85
PANTOPRAZOLE SODIUM 81 80 52 44
HUMULIN N 81 78 52 103
ASPIRIN EC 78 78 54 24
EVISTA 73 73 55 83
SPIRONOLACTONE 69 66 56 37
QUINAPRIL HCL 69 54 56 58
SERTRALINE HCL 67 62 58 64
LEVOXYL 67 67 58 59
DIPYRIDAMOLE 66 66 R 60 105
CILOSTAZOL 66 66 60 57
BUMETANIDE 66 59 60 98
AVAPRO 65 61 63 41
TEKTURNA 65 64 63 132
ATACAND HCT 64 53 10 65 124
ZETIA 64 57 65 39
GLIPIZIDE ER 62 56 67 87
GLYBURIDE-METFORMIN HCL 62 56 R 67 56
MELOXICAM 60 58 69 195
IBANDRONATE SODIUM 58 58 70 197
RAMIPRIL 57 50 71 33
INDAPAMIDE 57 53 71 48
FENOFIBRATE 56 50 73 36
DICLOFENAC POTASSIUM 55 47 74 113
CARTIA XT 55 53 74 80
GEMFIBROZIL 55 55 74 63
GLIPIZIDE XL 54 50 77 90
NIFEDIPINE ER 54 48 77 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 20, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.